Sheffield based web and marketing company, Omni, is celebrating the successful growth and acquisition of one of its clients as a real success.
Omni has worked with EMMAC Life Sciences Group since its creation in June 2018 and has been responsible for many aspects of the company’s ongoing digital strategy.
EMMAC Life Sciences Group is now the largest vertically integrated medical cannabis company in Europe following its recent $345M USD acquisition by CuraLeaf Holdings, Inc.
Alistair Hague, sales and operations director at Omni Digital Marketing, said: “We are extremely proud to have worked with EMMAC Life Sciences since they started their business in 2018. To have played even a small part in their incredible growth is amazing.
“The company has, in less than three years, completed a deal that means it is now the largest vertically integrated medical cannabis company in Europe – that is impressive!
“We worked closely with EMMAC on the design, launch, and management of the company’s digital presence in Germany, Switzerland, Spain, and the UK, in addition to providing ongoing web, email, and social media management.
“Our role is to support our clients to help them to meet their growth potential and this is a fantastic success story from our Sheffield based team.”
EMMAC is the largest independently fully integrated medical cannabis company in Europe with an existing platform for cultivation, EU-GMP-certified processing, distribution, and research & development operations across major European medical cannabis markets.
Antonio Costanzo, Chief Executive Officer at EMMAC, said: “CuraLeaf’s acquisition of EMMAC is not only a significant milestone for EMMAC but for the European cannabis market as a whole. As part of CuraLeaf, a well-capitalised leader of the US cannabis market, EMMAC is poised to exploit the rapid pace of growth of the European market, driven by regulatory change and the increasing demand for access to premium quality cannabis products.
“The combination of CuraLeaf and EMMAC creates a global platform to address these large new opportunities across Europe. With EMMAC’s science-led approach, wealth of local market experience, as well as our network of supply and distribution partnerships throughout Europe, we are now uniquely positioned to reinforce our place as one of Europe’s leaders in the production and supply of medical cannabis, wellness CBD, hemp and other derivative products.”
Hannah Du Beke, Group Head of Marketing and Communications at EMMAC, commented: “This is the start of an exciting new chapter for EMMAC. We are lucky to have found the right partners in OMNI to support us in our early years to help us to reach our desired growth ambitions.”
“The team at Omni have provided critical digital marketing support to EMMAC and I look forward to working with them to develop our digital strategy to support our next phase of growth. ”
For further information about Omni visit www.omnidigitalmarketing.co.uk